IL6 and dilated cardiomyopathy: In particular, beta-blocker initiation led to a decrease in circulating TNFα in patients with dilated cardiomyopathy [42], whereas a higher dose of ACE-I reduced circulating Interleukin-6 in individuals with chronic congestive heart failure more than a lower dose [43].